BDNF and obesity due to melanocortin 4 receptor deficiency: Strengths of our study included its novelty, and a high risk clinical sample of youth with obesity who exhibit greater incidence of BDNF-related complications such as neurocognitive deficits (Liang et al., 2016) and metabolic dysregulation (Krabbe et al., 2007) compared to peers without obesity.